These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 602749)

  • 1. Cystic fibrosis: a HLA associated hereditary disease?
    Kaiser GI; László A; Gyurkovits K
    Acta Paediatr Acad Sci Hung; 1977; 18(1):27-9. PubMed ID: 602749
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Distribution of serum amylase isoenzymes in cystic fibrosis homozygotes and heterozygotes.
    Takács O; Sohár I; László A; Pénzes P; Gyurkovits K
    Acta Paediatr Acad Sci Hung; 1977; 18(1):21-6. PubMed ID: 602748
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sweat chloride concentrations in infants homozygous or heterozygous for F508 cystic fibrosis.
    Farrell PM; Koscik RE
    Pediatrics; 1996 Apr; 97(4):524-8. PubMed ID: 8632940
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cystic fibrosis: present status and future prospects in detection of patients and carriers.
    Forstner G; Crozier DN; Sturgess JM
    Can Med Assoc J; 1975 Sep; 113(6):550-6. PubMed ID: 1156983
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum CA 19-9 levels as a diagnostic marker in cystic fibrosis patients with borderline sweat tests.
    Augarten A; Berman H; Aviram M; Diver-Habber A; Akons H; Ben Tur L; Blau H; Kerem E; Rivlin J; Katznelson D; Szeinberg A; Kerem BS; Theodor L; Paret G; Yahav Y
    Clin Exp Med; 2003 Sep; 3(2):119-23. PubMed ID: 14598187
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Detection of mucoviscidosis heterozygotes by the bromide sweat test].
    Hager-Malecka B; Szczepański Z
    Pol Tyg Lek; 1969 May; 24(21):792-4. PubMed ID: 5804329
    [No Abstract]   [Full Text] [Related]  

  • 7. Detection of cystic fibrosis heterozygotes using the zeta potential reduction method.
    Litt M; Khan MA
    Tex Rep Biol Med; 1976; 34(1):151-4. PubMed ID: 996785
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cystic fibrosis. In vitro and in vivo studies on the biochemical background to the pathogenesis.
    Ceder O
    Acta Paediatr Scand Suppl; 1983; 309():1-47. PubMed ID: 6581681
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cystic fibrosis. Carbohydrate metabolism in CF and in animal models for CF.
    Bardoń A
    Acta Paediatr Scand Suppl; 1987; 332():1-30. PubMed ID: 3474861
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Bromide test using ion-selective membrane electrodes in the demonstration of heterozygotes among patients with mucoviscidosis].
    Gyurkovits K; László A
    Orv Hetil; 1974 Aug; 115(33):1943-4. PubMed ID: 4846377
    [No Abstract]   [Full Text] [Related]  

  • 11. Serum complement C2 levels in patients suffering from cystic fibrosis (CF).
    László A; Füst G; Pánya A; Gyurkovits K
    Acta Paediatr Hung; 1988-1989; 29(3-4):289-92. PubMed ID: 3269267
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Characteristics and specificities of cystic fibrosis in adults: evolutive disease of childhood or recently diagnosed disease?].
    Hubert D; Rivoal V; Desmazes-Dufeu N; Lacronique J; Maurer C; Richaud-Thiriez B; Dusser D
    Rev Mal Respir; 2000 Aug; 17(3 Pt 2):749-57. PubMed ID: 11076385
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pancreatic function and extended mutation analysis in DeltaF508 heterozygous infants with an elevated immunoreactive trypsinogen but normal sweat electrolyte levels.
    Massie RJ; Wilcken B; Van Asperen P; Dorney S; Gruca M; Wiley V; Gaskin K
    J Pediatr; 2000 Aug; 137(2):214-20. PubMed ID: 10931414
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Application of the cilia dyskinesis test in the diagnosis of cystic fibrosis in an adolescent.
    Arad I; Lafair JS; Shapira E
    Isr J Med Sci; 1975 Jan; 11(1):10-4. PubMed ID: 1167850
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of polyamines and cystic fibrosis serum on glucose transport.
    Arvanitakis S; Mangos J; McSherry NR; Rennert O
    Tex Rep Biol Med; 1976; 34(1):175-86. PubMed ID: 996787
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Missense mutation R1066C in the second transmembrane domain of CFTR causes a severe cystic fibrosis phenotype: study of 19 heterozygous and 2 homozygous patients.
    Casals T; Pacheco P; Barreto C; Giménez J; Ramos MD; Pereira S; Pinheiro JA; Cobos N; Curvelo A; Vázquez C; Rocha H; Séculi JL; Pérez E; Dapena J; Carrilho E; Duarte A; Palacio AM; Nunes V; Lavinha J; Estivill X
    Hum Mutat; 1997; 10(5):387-92. PubMed ID: 9375855
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mucoviscidosis: total amylase activity of serum and mixed saliva in homozygous and heterozygous subjects.
    László A; Pénzes P; Gyurkovits K
    Acta Paediatr Acad Sci Hung; 1976; 17(4):293-6. PubMed ID: 1030165
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HLA haplotypes in children with adrenogenital syndrome and their parents.
    László A; Godó B; Kaiser G; Hajdu J; Fazekas C
    Acta Paediatr Acad Sci Hung; 1981; 22(3):217-22. PubMed ID: 7304161
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pancreatitis among patients with cystic fibrosis: correlation with pancreatic status and genotype.
    De Boeck K; Weren M; Proesmans M; Kerem E
    Pediatrics; 2005 Apr; 115(4):e463-9. PubMed ID: 15772171
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical spectrum in homozygotes and compound heterozygotes inheriting cystic fibrosis mutation 3849 + 10kbC > T: significance for geneticists.
    Gilbert F; Li Z; Arzimanoglou II; Bialer M; Denning C; Gorvoy J; Honorof J; Ores C; Quittell L; Arzimanoglou I
    Am J Med Genet; 1995 Sep; 58(4):356-9. PubMed ID: 8533846
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.